Hunter McGrady
Hunter McGrady HUNTER MCGRADY/INSTAGRAM

Hunter McGrady turned heads after sharing a glamorous swimsuit snap while delivering a candid message about the growing conversation surrounding GLP-1 weight-loss medications.

Rather than criticising the drugs, the Sports Illustrated Swimsuit model argued that society's reaction to weight loss is what should concern people most, saying the real issue is the praise women receive simply for becoming smaller.

The 33-year-old model shared her thoughts as GLP-1 medications such as Ozempic and Wegovy continue to reshape conversations around body image, fashion and beauty standards. While acknowledging the health benefits these treatments can provide, McGrady questioned why thinner bodies continue to attract the loudest applause.

Hunter McGrady Says the Conversation Shouldn't Be About GLP-1 Drugs

McGrady made it clear that she does not see GLP-1 medications as the problem, noting that they have improved the lives of many people living with health conditions.

'I don't think GLP-1s are the problem', she said.

'For so many people, they've improved health, lowered inflammation, lowered blood pressure, and changed lives. That's worth celebrating. What concerns me is the cultural response.'

Instead, McGrady said she has become increasingly uneasy about what happens after women lose weight.

'I've noticed the loudest applause isn't for the improved health markers. It's for the smaller body', she explained.

She argued that when someone reports healthier blood pressure, reduced inflammation or more energy to spend with their children, those milestones deserve recognition. Yet, she believes those achievements are often overshadowed by compliments about physical appearance.

According to McGrady, the conversation has become less about health and more about shrinking bodies.

'I think that's the deeper issue', she said, explaining that the praise surrounding weight loss reflects longstanding beauty standards rather than genuine concern for wellbeing.

Her comments come amid continued debate over the growing popularity of GLP-1 medications, which have become widely discussed both within Hollywood and across the fashion industry.

Model Warns Fashion Could Be Moving Away From Size Inclusivity

McGrady also expressed concern that the fashion industry's commitment to body diversity appears to be weakening.

Although she appeared on the cover of Sports Illustrated Swimsuit in 2024, she said she began noticing signs that extended sizing and inclusive representation were already disappearing.

Brands, she said, were quietly reducing plus-size collections, while campaigns featuring a wider range of body types became less common.

Having made her Sports Illustrated Swimsuit debut in 2017, McGrady has become one of fashion's most recognisable plus-size models and has consistently advocated for greater representation throughout her career.

She warned that fewer opportunities for plus-size women in fashion send a troubling message to consumers who had finally begun to see themselves represented.

'Representation isn't an idea. It's an experience', McGrady said.

'Many of us know what it feels like to be seen, and I'm not willing to accept invisibility again.'

The model also reflected on her role as a mother, saying she hopes her daughter grows up believing beauty exists in many different forms rather than being limited to one body type.

Despite her concerns, McGrady remains hopeful that younger generations will continue pushing for broader representation and reject the idea that becoming smaller should be the ultimate measure of success.

For McGrady, the message is not about discouraging anyone from using GLP-1 medication. Instead, she believes society should celebrate improved health without treating weight loss as the defining achievement, arguing that a woman's value should never be determined by her body size.